Efficacy of fimaSartan on arTerIal stiFFness iN patiEntS With HypertenSion

NCT02022774 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2023-07-06

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects of fimasartan on arterial stiffness in patients with hypertension

Conditions

Interventions

DRUG

Fimasartan

Fimasartan 60 \~ 120 mg/po take one tablet once a day

Sponsors & Collaborators

  • Boryung Pharmaceutical Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Kye Hun Kim, MD · Chonnam National University Hospital

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02022774 on ClinicalTrials.gov